KJIM :: Korean Journal of Internal Medicine

Insulin Requirement for Gestational Diabetes Control Is Related to Higher Vitamin D Levels up to 1 Year Postpartum: A Prospective Cohort Study

María Molina-Vega, María José Picón-César, Fuensanta Lima-Rubio, Carolina Gutiérrez-Repiso, Teresa María Linares-Pineda, María Suárez-Arana, Ana María Fernández-Ramos, Francisco J. Tinahones, Sonsoles Morcillo

Effect of short-term intensive insulin therapy on α-cell function in patients with newly diagnosed type 2 diabetes

Hai-Lan Zheng, Yan Xing, Fan Li, Wei Ding, Shan-Dong Ye

Delay in starting insulin therapy in patients with type 2 Diabetes Mellitus

Semih KALYON, Perihan ÖZKAN GÜMÜŞKAYA, Neslihan ÖZSOY, Mustafa ÖZCAN, Ayşe PALA, Ayşe BASMAKÇI, Yücel ARMAN, Tufan TÜKEK

Journal of Surgery and Medicine.2020; 4(8): 685. CrossRef

Impact Metformin and Insulin Therapy on Parathyroid Hormone and 25 (OH) Vitamin D in Diabetic Post-menopausal Iraqi Women

Ali B. Roomi, Raid M. H. AL-Salih, Saher A. Ali

Journal of Physics: Conference Series.2019; 1279(1): 012008. CrossRef

Influence of comorbidities on the implementation of the fundus examination in patients with newly diagnosed type 2 diabetes

Taichi Kawamura, Izumi Sato, Hiroshi Tamura, Yoko M. Nakao, Koji Kawakami

Japanese Journal of Ophthalmology.2018; 62(1): 68. CrossRef

Lower mean blood glucose during short‐term intensive insulin therapy is associated with long‐term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence‐based recommendations for standardization

Liehua Liu, Juan Liu, Lijuan Xu, Weijian Ke, Xuesi Wan, Hai Li, Xiaoying He, Liangjiao Wang, Xiaopei Cao, Haipeng Xiao, Yanbing Li

Journal of Diabetes Investigation.2018; 9(4): 908. CrossRef

Long‐term effects on glycaemic control and β‐cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial

Suk Chon, Sang Youl Rhee, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Soon Jib Yoo, Gwanpyo Koh, Dae Ho Lee, Young Seol Kim, Jeong‐Taek Woo

Diabetes, Obesity and Metabolism.2018; 20(5): 1121. CrossRef

A consensual therapeutic recommendation for type 2 diabetes mellitus by the Slovak Diabetes Society (2018)

Emil Martinka, Vladimír Uličiansky, Marián Mokáň, Ivan Tkáč, Peter Galajda, Silvia Dókušová, Zbynek Schroner

Vnitřní lékařství.2018; 64(4): 405. CrossRef

Short‐term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9%

Journal of Diabetes.2017; 9(10): 890. CrossRef

β-Cell Function Over Time in Adolescents With New Type 2 Diabetes and Obese Adolescents Without Diabetes

Deborah A. Elder, Lindsey N. Hornung, Jane C. Khoury, David A. D'Alessio

Journal of Adolescent Health.2017; 61(6): 703. CrossRef

Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials

Markolf Hanefeld, Louis Monnier, Oliver Schnell, David Owens

Diabetes Therapy.2016; 7(2): 187. CrossRef

Pancreatic β‐cell identity in diabetes

Diabetes, Obesity and Metabolism.2016; 18(S1): 110. CrossRef

Short‐term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps

Jianping Weng, Ravi Retnakaran, Ammini Ariachery C, Linong Ji, Luigi Meneghini, Wenying Yang, Jeong‐Taek Woo

Diabetes/Metabolism Research and Reviews.2015; 31(6): 537. CrossRef

Efficacy of metformin‐based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short‐term intensive insulin therapy

Qingfeng Cheng, Shumin Yang, Changhong Zhao, Zhihong Wang, Zhengping Feng, Rong Li, Peng Ye, Suhua Zhang, Huacong Deng, Bo Zhou, Jian Long, Lilin Gong, Hua Qing, Cheng Luo, Qifu Li

Journal of Diabetes.2015; 7(2): 182. CrossRef

Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease

Qing Li, Luan Wang, Lin Xiao, Zhongchao Wang, Fang Wang, Xiaolong Yu, Shengli Yan, Yangang Wang

Experimental and Therapeutic Medicine.2014;[Epub] CrossRef

Resultados a medio plazo de un programa de insulinización en régimen de Hospital de Día para pacientes con diabetes tipo 2

Carmen Quirós, Antonio J. Amor, Ana M. de Hollanda, Gemma Yago, Pilar Ara, Ignacio Conget

Medicina Clínica.2014; 142(6): 243. CrossRef

Timely commencement of insulin in type 2 diabetes: benefits and risks

Orvosi Hetilap.2014; 155(7): 255. CrossRef

Predictors of Response to Early Basal Insulin Treatment in Patients with Type 2 Diabetes—The EARLY Experience

Markolf Hanefeld, Holger Fleischmann, Guido Schiffhorst, Peter Bramlage

Diabetes Technology & Therapeutics.2014; 16(4): 241. CrossRef

Use of insulin in type 2 diabetes: What we learned from recent clinical trials on the benefits of early insulin initiation

Diabetes & Metabolism.2014; 40(6): 391. CrossRef

Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes

Diabetes Technology & Therapeutics.2013; 15(9): 776. CrossRef

Choice of early treatment regimen and impact on β-cell preservation in type 2 diabetes

International Journal of Clinical Practice.2013; 67(9): 876. CrossRef

Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial

Current Diabetes Reports.2013; 13(3): 342. CrossRef

Long term effects of the implantation of autologous bone marrow mononuclear cells for type 2 diabetes mellitus

Jianxia Hu, Chengqian Li, Li Wang, Xuefeng Zhang, Meirong Zhang, Hong Gao, Xiaolong Yu, Fang Wang, Wenjuan Zhao, Shengli Yan, Yangang Wang

Endocrine Journal.2012; 59(11): 1031. CrossRef